BlackLine Inc header image

BlackLine Inc

BL

Equity

ISIN null / Valor 34173457

NASDAQ (2025-11-17)
USD 52.49-3.99%

BlackLine Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

BlackLine Inc is a prominent provider of cloud software that specializes in automating and managing financial close and accounting processes. Founded in 2001, the company has established itself as a leader in the industry, offering innovative solutions to streamline and optimize financial operations for businesses of all sizes. With a focus on efficiency and accuracy, BlackLine's software helps organizations improve their financial reporting and compliance, ultimately driving better decision-making and business performance.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (03.10.2025):

BlackLine Inc reported strong financial performance in the second quarter of 2025, demonstrating growth in revenues and operational efficiency. The company's disciplined go-to-market execution and strategic initiatives have significantly contributed to its success, positioning BlackLine for continued advancement in the financial technology sector.

Revenue Growth

Total GAAP revenues reached $172.0 million in the second quarter of 2025, marking a 7% increase compared to the same quarter in 2024.

Improved Operating Margins

The GAAP operating margin rose to 4.4%, up from 1.4% in the second quarter of 2024. Additionally, the non-GAAP operating margin increased to 22.1%, compared to 19.8% in the prior year.

Net Income Performance

GAAP net income attributable to BlackLine was $8.3 million, or $0.13 per diluted share, down from $76.7 million, or $0.221 per diluted share in the second quarter of 2024. Non-GAAP net income was $37.9 million, or $0.51 per diluted share, compared to $42.9 million, or $0.58 per diluted share in the same period last year.

Billings and Performance Obligations

Billings increased by 11% to $182.3 million, while remaining performance obligations grew by 11% to $944.3 million compared to the second quarter of 2024.

Cash Flow Metrics

Operating cash flow was $32.3 million, a decrease from $40.7 million in the second quarter of 2024. Free cash flow stood at $25.4 million, down from $34.4 million in the same period last year.

Summarized from source with an LLMView Source

Key figures

-11.5%1Y
-15.0%3Y
-50.5%5Y

Performance

37.7%1Y
39.6%3Y
42.9%5Y

Volatility

Market cap

3248 M

Market cap (USD)

Daily traded volume (Shares)

967,896

Daily traded volume (Shares)

1 day high/low

60.915 / 59.63

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Pegasystems Inc
Pegasystems Inc Pegasystems Inc Valor: 503997
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.87%USD 54.65
NVIDIA Corp
NVIDIA Corp NVIDIA Corp Valor: 994529
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.88%USD 182.96
Meta Platforms Inc
Meta Platforms Inc Meta Platforms Inc Valor: 14917609
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.22%USD 592.67
Rubean AG
Rubean AG Rubean AG Valor: 33095126
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.54%EUR 5.00
Halozyme Therapeutics Inc
Halozyme Therapeutics Inc Halozyme Therapeutics Inc Valor: 1814799
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.76%USD 70.56
Tarsus Pharmaceuticals Inc
Tarsus Pharmaceuticals Inc Tarsus Pharmaceuticals Inc Valor: 57410241
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.71%USD 74.17
Flywire Corp
Flywire Corp Flywire Corp Valor: 111444572
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.51%USD 13.57
Sezzle Inc
Sezzle Inc Sezzle Inc Valor: 129105133
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.24%USD 50.97
PAR Technology Corporation
PAR Technology Corporation PAR Technology Corporation Valor: 960461
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.66%USD 36.70
Eli Lilly & Co
Eli Lilly & Co Eli Lilly & Co Valor: 947556
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.35%USD 1,035.62